Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 505

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Minireview: Aromatase and the Regulation of Estrogen Biosynthesis—Some New Perspectives

Open access
Simpson, Evan R., Davis, Susan R.·2001·Endocrinology
DOI 10.1210/endo.142.11.8547
Open this paper in CoChat — free account

Abstract

There is a growing awareness that androgens and estrogens have general metabolic roles that are not directly involved in reproductive processes. These include actions on vascular function, lipid and carbohydrate metabolism, as well as bone mineralization and epiphyseal closure, in both sexes. In postmenopausal women, as in men, estrogen is no longer solely an endocrine factor, but instead is produced in a number of extragonadal sites and acts locally at these sites in a paracrine and intracrine fashion. These sites include breast, bone, vasculature, and brain. Within these sites, aromatase action can generate high levels of E2 locally without significantly affecting circulating levels. Circulating C(19) steroid precursors are essential substrates for extragonadal estrogen synthesis. The levels of these androgenic precursors decline markedly with advancing age in women, possibly from the mid to late reproductive years. This may be a fundamental reason why women are at increased risk for bone mineral loss and fracture and possibly decline of cognitive function, compared with men. Aromatase expression in these various sites is under the control of tissue-specific promoters regulated by different cohorts of transcription factors. Thus, in principle, it should be possible to develop selective aromatase modulators that block aromatase expression, for example, in breast, but allow unimpaired estrogen synthesis in other tissues such as bone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endo.142.11.8547

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 45

  1. Simpson, 2000, The role of local estrogen biosynthesis in males and females., Trends Endocrinol Metab, 11, 184, 10.1016/S1043-2760(00)00254-X · DOI · Paper page
  2. Lubahn, 1993, Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene., Proc Natl Acad Sci USA, 90, 11162, 10.1073/pnas.90.23.11162 · DOI · Paper page
  3. Krege, 1998, Generation and reproductive phenotypes of mice lacking estrogen receptor-β., Proc Natl Acad Sci USA, 95, 15677, 10.1073/pnas.95.26.15677 · DOI · Paper page
  4. Couse, 1999, Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β., Science, 286, 2328, 10.1126/science.286.5448.2328 · DOI · Paper page
  5. Dupont, 2000, Effect of single and compound knockouts of estrogen receptor α (ERα) and β (ERβ) on mouse reproductive phenotypes, Development, 127, 4277, 10.1242/dev.127.19.4277 · DOI · Paper page
  6. Honda, 1998, Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene., Biochem Biophys Res Commun, 252, 445, 10.1006/bbrc.1998.9672 · DOI · Paper page
  7. Nemoto, 2000, Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice., J Clin Invest, 105, 1819, 10.1172/JCI9575 · DOI
  8. Jones, 2000, Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity, Proc Natl Acad Sci USA, 97, 12735, 10.1073/pnas.97.23.12735 · DOI · Paper page
  9. Heine, 2000, Increased adipose tissue in male and female estrogen receptor-α knockout mice., Proc Natl Acad Sci USA, 97, 12729, 10.1073/pnas.97.23.12729 · DOI · Paper page
  10. Oz, 2000, Bone has a sexually dimorphic response to aromatase deficiency., J Bone Miner Res, 15, 507, 10.1359/jbmr.2000.15.3.507 · DOI
  11. Robertson, 1999, Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene., Proc Natl Acad Sci USA, 96, 7986, 10.1073/pnas.96.14.7986 · DOI · Paper page
  12. Pentikainen, 2000, Estradiol acts as a germ cell survivor factor in the human testis in vitro., J Clin Endocrinol Metab, 85, 2057
  13. Eddy, 1996, Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility., Endocrinology, 137, 4796, 10.1210/endo.137.11.8895349 · DOI · Paper page
  14. Nakai, 2001, Morphological analysis of endocytosis in efferent ductules of estrogen receptor-α knockout male mouse, Anat. Rec., 263, 10, 10.1002/ar.1071 · DOI
  15. Nelson, 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature., Pharmacogenetics, 6, 1, 10.1097/00008571-199602000-00002 · DOI · Paper page
  16. Means, 1989, Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis., J Biol Chem, 264, 19385, 10.1016/S0021-9258(19)47313-4 · DOI · Paper page
  17. Harada, 1990, Structural characterization of the human estrogen synthetase (aromatase) gene., Biochem Biophys Res Commun, 166, 365, 10.1016/0006-291X(90)91954-Q · DOI
  18. Toda, 1990, Structural and functional characterization of human aromatase P450 gene., Eur J Biochem, 193, 559, 10.1111/j.1432-1033.1990.tb19372.x · DOI
  19. Zeitoun, 1999, Stimulation of aromatase promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-I and chicken ovalbumin upstram promoter transcription factor to the same cis-acting element., Mol Endocrinol, 13, 239, 10.1210/mend.13.2.0229 · DOI · Paper page
  20. Shozu, 1998, Aromatase expression of human osteoblast-like cells., Mol Cell Endocrinol, 139, 117, 10.1016/S0303-7207(98)00069-0 · DOI
  21. Michael, 1995, Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary., J Biol Chem, 270, 13561, 10.1074/jbc.270.22.13561 · DOI
  22. Zhao, 1996, Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene., Endocrinology, 137, 5739, 10.1210/endo.137.12.8940410 · DOI · Paper page
  23. Simpson, 1997, Aromatase expression in health and disease., Recent Prog Horm Res, 52, 185
  24. Callard, 1978, Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system., Endocrinology, 103, 2283, 10.1210/endo-103-6-2283 · DOI · Paper page
  25. Kishida, 2001, Distinct cytochrome P450 aromatase isoforms in zebrafish (D. rerio) brain and ovary are differentially regulated during early development., Endocrinology, 142, 740, 10.1210/endo.142.2.7928 · DOI · Paper page
  26. Thornton, 2001, Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions., Proc Natl Acad Sci USA, 98, 5671, 10.1073/pnas.091553298 · DOI · Paper page
  27. Labrie, 1998, DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging., Steroids, 63, 322, 10.1016/S0039-128X(98)00007-5 · DOI · Paper page
  28. Wilson, 1980, The pathogenesis of gynecomastia., Adv Intern Med, 25, 1
  29. Pasqualini, 1996, Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients., J Clin Endocrinol Metab, 81, 1460
  30. Castagnetta, 1996, Estrogen content and metabolism in human breast tumor tissue and cells., Ann NY Acad Sci, 784, 314, 10.1111/j.1749-6632.1996.tb16246.x · DOI
  31. DeJong, 1997, Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor varozole., Cancer Res, 57, 2109
  32. Bulun, 2000, Aromatase as a therapeutic target in endometriosis., Trends Endocrinol Metab, 11, 22, 10.1016/S1043-2760(99)00216-7 · DOI
  33. Sasano, 1997, Aromatase in bone tissue., J Bone Miner Res, 12, 1416, 10.1359/jbmr.1997.12.9.1416 · DOI · Paper page
  34. Zhao, 1995, Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in the regulation of the adipose-specific promoter., J Biol Chem, 270, 16449, 10.1074/jbc.270.27.16449 · DOI · Paper page
  35. Zhao, 1996, Tumor necrosis factor-α stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter I.4., Mol Endocrinol, 10, 1350
  36. Singh, 1999, The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2., Endocrine Related Cancer, 6, 139, 10.1677/erc.0.0060139 · DOI
  37. Rubin, 2000, Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy., Cancer Res, 60, 1604
  38. Harada, 1993, Tissue-specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis., Proc Natl Acad Sci USA, 90, 11312, 10.1073/pnas.90.23.11312 · DOI · Paper page
  39. Zhou, 1997, Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells., J Steroid Biochem Mol Biol, 61, 273, 10.1016/S0960-0760(97)80023-4 · DOI
  40. Agarwal, 1996, Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients., J Clin Endocrinol Metab, 81, 3843
  41. Zhou, 2001, Malignant breast epithelial cells stimiulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding proteinβ ., Cancer Res, 61, 2328
  42. Schrey, 1995, Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators., Br J Cancer, 72, 1412, 10.1038/bjc.1995.523 · DOI
  43. Brueggemeier, 1999, Correlation of aromatase and cycloxygenase gene expression in human breast cancer specimens., Cancer Lett, 140, 27, 10.1016/S0304-3835(99)00050-6 · DOI
  44. Harris, 1996, Non-steroidal anti-inflammatory drugs and breast cancer., Epidemiology, 7, 203, 10.1097/00001648-199603000-00017 · DOI · Paper page
  45. Harris, 2000, Chemoprevention of breast cancer in rats by celecoxib, a cycloxygenase 2 inhibitor., Cancer Res, 60, 2101

Cited by

Metadata

Authors
Simpson, E. R., & Davis, S. R.
Venue
Endocrinology
Publisher
The Endocrine Society
Published
2001-11-01
Volume
142
Issue
11
Pages
4589-4594
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
DOI
10.1210/endo.142.11.8547
OpenAlex
W1984858425
Cited by
505
References
8
FWCI
10.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.